Internal Medicine, Hematology & Oncology · Asheville, NC
NPI
1881855948
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
551 Brevard Rd
Asheville, NC, 28806
Phone (828) 212-7021
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.6M
146,247 services
Medicare patients, 2024
933
Average age 75
Drug cost, 2024
$4.5M
1,933 prescriptions
Company payments, 2025
$999
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew R Beardsley was code J9271 (injection, pembrolizumab, 1 mg), 25,600 times for 36 patients. In total Andrew R Beardsley billed 146,247 services in 169 codes, and Medicare paid $3.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 25,600 | 36 | $44.73 | $1.1M |
| J0185 Injection, aprepitant, 1 mg | Office | 11,310 | 36 | $1.35 | $15K |
| J9025 Injection, azacitidine, 1 mg | Office | 10,300 | 11 | $0.30 | $3,075 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 8,640 | 18 | $39.60 | $342K |
| J9299 Injection, nivolumab, 1 mg | Office | 6,960 | 14 | $24.65 | $172K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 3,000 | 28 | $15.75 | $47K |
| J9267 Injection, paclitaxel, 1 mg | Office | 2,828 | 15 | $0.08 | $222 |
| J9041 Injection, bortezomib, 0.1 mg | Office | 2,240 | 16 | $1.45 | $3,238 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,100 | 16 | $0.11 | $225 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,847 | 71 | $0.09 | $166 |
| J0897 Injection, denosumab, 1 mg | Office | 1,680 | 18 | $21.02 | $35K |
| 85025 Blood Count | Office | 1,321 | 586 | $7.60 | $10K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,280 | 55 | $0.68 | $875 |
| 36415 Venipuncture Blood Collection | Office | 1,278 | 576 | $8.64 | $11K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,120 | 13 | $6.05 | $6,770 |
By year: 2022 $2.7M for 127,323 services; 2023 $2.1M for 88,105 services; 2024 $3.6M for 146,247 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,321 | 586 | $7.60 | $10K |
| 36415 Venipuncture Blood Collection | 1,278 | 576 | $8.64 | $11K |
| 81002 Clinical Chemistry | 54 | 33 | $3.41 | $184 |
| 85045 Blood Count | 40 | 37 | $3.91 | $156 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew R Beardsley prescribed most often to Medicare patients was Prednisone, with 152 prescriptions and refills. In total Andrew R Beardsley wrote 1,933 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 152 | 228 | 56 | $722 |
| Ondansetron Odt Ondansetron | 128 | 129 | 81 | $2,847 |
| Oxycodone Hcl Generic | 101 | 102 | 33 | $2,583 |
| Acyclovir Generic | 91 | 126 | 22 | $1,098 |
| Eliquis Apixaban | 90 | 114 | 17 | $64K |
| Abiraterone Acetate Generic | 84 | 98 | 14 | $130K |
| Prochlorperazine Maleate Generic | 71 | 71 | 43 | $1,106 |
| Dexamethasone Generic | 55 | 62 | 34 | $954 |
| Gabapentin Generic | 50 | 60 | 12 | $648 |
| Imfinzi Durvalumab | 41 | 41 | Under 11 | $350K |
| Hydroxyurea Generic | 40 | 57 | Under 11 | $877 |
| Imbruvica Ibrutinib | 38 | 38 | Under 11 | $458K |
| Revlimid Lenalidomide | 35 | 35 | Under 11 | $551K |
| Hydrocortisone Generic | 34 | 58 | 13 | $1,249 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 34 | 34 | Under 11 | $1,316 |
Brand drugs: 446 claims; generic drugs: 1,487 claims; opioid claims: 194.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew R Beardsley $999 ($999 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $158.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $158 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $100 |
| Incyte Corporation INCY | 1 | $99.95 |
| Janssen Biotech, Inc. JNJ | 4 | $96.48 |
| Pfizer Inc. PFE | 6 | $85.67 |
| Abbvie Inc. ABBV | 4 | $72.21 |
| Merck Sharp & Dohme LLC MRK | 3 | $59.68 |
| Array Biopharma Inc PFE | 2 | $49.13 |
| BeOne Medicines USA, Inc. ONC | 2 | $43.14 |
| Dendreon Pharmaceuticals LLC | 1 | $32.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.